Latest Clinical Trial Update and Real-World Cases: Which CAR-T, Bispecific Antibody, and Gene Therapies Are Accessible to Patients?

April 2026 global update on CAR-T, bispecific antibodies, and gene therapy clinical trials, including real-world cases and patient access insights.

Top Stories

Breakthrough with CAR-NK Plus PD-1: Survival in Advanced Colorectal Cancer Exceeds 700 Days

China’s First Original Radiopharmaceutical Approved: 99mTc-Pexidartide (Giluntai) Enables Precision Lung Cancer Diagnosis

Latest Coverage

From the Chemotherapy Era to the Precision Medicine Era: What Has Changed in Medical Logic?
From the Chemotherapy Era to the Precision Medicine Era: What Has Changed in Medical Logic?

Mechanism of Action of HLX3901: How a Tetraspecific Antibody Simultaneously Targets DLL3, CD3, and CD28
Mechanism of Action of HLX3901

Advances in the Treatment of HER2-Mutant Advanced Non-Small Cell Lung Cancer
Advances in the Treatment of HER2-Mutant Advanced Non-Small Cell Lung Cancer

Covering Nearly 20 Rare Diseases: A Comprehensive Overview of Newly Approved Rare Disease Drugs Worldwide in March 2026
Introduction

From Single-Target Inhibition to Network-Level Intervention: A Paradigm Shift in KRAS-Mutant Cancer Therapy
Introduction

Latest Advances in Gene Therapy: From Genetic Disorders to Cancer Treatment
Latest Advances in Gene Therapy: From Genetic Disorders to Cancer Treatment

In-Depth Analysis

Latest Clinical Trial Update and Real-World Cases: Which CAR-T, Bispecific Antibody, and Gene Therapies Are Accessible to Patients?

Breakthrough with CAR-NK Plus PD-1: Survival in Advanced Colorectal Cancer Exceeds 700 Days

China’s First Original Radiopharmaceutical Approved: 99mTc-Pexidartide (Giluntai) Enables Precision Lung Cancer Diagnosis

From the Chemotherapy Era to the Precision Medicine Era: What Has Changed in Medical Logic?